Skip to main content

Corteva, Inc.

For the period ended Mar 31, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

CTVA$12.11+1.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Revenue

NOTE 3 -REVENUE

Remaining Performance Obligations

Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $147 million, $150 million and $135 million at March 31, 2026, December 31, 2025 and March 31, 2025, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over a period ofsix years.

Contract Balances

Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.

Contract BalancesMarch 31, 2026December 31, 2025March 31, 2025
(In millions)
Contract assets - current 1$34$34$30
Contract assets - noncurrent 2$82$83$73
Deferred revenue - current$2,773$3,579$2,631
Deferred revenue - noncurrent 3$113$125$111
  1. Included in other current assets in the interim Consolidated Balance Sheets.

  2. Included in other assets in the interim Consolidated Balance Sheets.

  3. Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the three months ended March 31, 2026 and 2025 from amounts included in deferred revenue at the beginning of the period was $1,268 million and $1,174 million, respectively.

Disaggregation of Revenue

Corteva's operations are classified intotwo operating segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:

Three Months Ended March 31,
(In millions)20262025
Corn$2,373$2,069
Soybean306305
Other oilseeds245223
Other99110
Seed3,0232,707
Herbicides1,027860
Insecticides377336
Fungicides334304
Biologicals7084
Other74126
Crop Protection1,8821,710
Total$4,905$4,417

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:

SeedThree Months Ended March 31,
(In millions)20262025
North America 1$1,770$1,597
EMEA 2928826
Latin America224185
Asia Pacific10199
Total$3,023$2,707
Crop ProtectionThree Months Ended March 31,
(In millions)20262025
North America 1$669$613
EMEA 2727651
Latin America282257
Asia Pacific204189
Total$1,882$1,710
  1. Represents U.S. and Canada.

  2. Europe, Middle East and Africa (“EMEA”).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.